Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Total 13F shares
-
87,701,562
-
Share change
-
+2,618,214
-
Total reported value
-
$3,644,892,889
-
Price per share
-
$41.56
-
Number of holders
-
115
-
Value change
-
+$108,159,345
-
Number of buys
-
64
-
Number of sells
-
30
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q4 2020
As of 31 Dec 2020,
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,701,562 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, TRV GP III, LLC, FMR LLC, Casdin Capital, LLC, EcoR1 Capital, LLC, BlackRock Inc., BVF INC/IL, TRV GP IV, LLC, PERCEPTIVE ADVISORS LLC, and Foresite Capital Management IV, LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.